Agarwal Industrial Corporation Limited (AGARIND.NS)
Mumbai, IN
Agarwal Industrial Corporation Limited (AICL) operates primarily in India, specializing in the production and commercialization of petrochemicals. Its business activities are segmented into petrochemicals, transportation services, and power generation. The company's comprehensive product lineup includes various grades of bitumen—such as paving, industrial, viscosity, crumb rubber modified, and polymer modified—along with bitumen emulsions vital for road construction. Additionally, AICL offers a range of related byproducts and waterproofing materials, including bituminous felts, expansion jointing boards, bitumen-based coatings and paints, insulation materials, and specialized compounds like bitubonds, bituplasts, bituminous blacks, bitukotes, bitupremier, and cable compounds. Beyond manufacturing, the company is involved in transporting bulk bitumen and liquefied petroleum gas (LPG), manages the import and storage of bitumen, and generates electricity through wind power. Established in 1995 and based in Mumbai, India, AICL was previously known as Bombay Baroda Roadways (India) Limited until its rebranding in March 2008.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.08% | -1.75% | +0.61% | -20.37% | -44.89% | -40.53% | -55.42% | -29.25% | +103.81% | +258.56% | +145.56% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-31.4% Q1'26: -51.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-86.4% Q1'26: +42.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+8.8% ★ Q1'26: +8.2% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+4.0% Q1'26: +4.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+5.6% ★ Q1'26: +6.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+176.6% Q1'26: -63.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.91× Q1'26: 2.63× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2017 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.24B
est: 2.46B (-8.7%)
|
2.97B
est: 2.34B (+26.8%)
|
7.87B
est: 6.81B (+15.5%)
|
9.04B
est: 7.91B (+14.3%)
|
15.98B
est: 15.84B (+0.9%)
|
20.15B
est: 32.22B (-37.5%)
|
21.25B
est: 2.42B (+777.9%)
|
24.09B
est: 2.86B (+743.5%)
|
2.31B
2.31B – 2.31B
-19.2% YoY
|
2.66B
2.66B – 2.66B
+15.0% YoY
|
6.71B
6.71B – 6.71B
+152.9% YoY
|
7.79B
7.79B – 7.79B
+16.0% YoY
|
| EBITDA |
167.46M
est: 191.29M (-12.5%)
|
266.31M
est: 178.84M (+48.9%)
|
484.91M
est: 520.08M (-6.8%)
|
725.91M
est: 603.29M (+20.3%)
|
1.08B
est: 479.58M (+125.9%)
|
1.45B
est: 2.52B (-42.6%)
|
1.78B
est: 238.60M (+646.7%)
|
2.06B
est: 281.54M (+631.8%)
|
227.55M
227.55M – 227.55M
-19.2% YoY
|
261.68M
261.68M – 261.68M
+15.0% YoY
|
661.75M
661.75M – 661.75M
+152.9% YoY
|
767.63M
767.63M – 767.63M
+16.0% YoY
|
| EBIT |
122.91M
est: 156.47M (-21.4%)
|
208.48M
est: 146.28M (+42.5%)
|
395.34M
est: 425.41M (-7.1%)
|
578.10M
est: 493.48M (+17.1%)
|
885.81M
est: 595.90M (+48.6%)
|
1.22B
est: 2.06B (-40.9%)
|
1.44B
est: 192.51M (+645.5%)
|
1.65B
est: 227.16M (+625.7%)
|
183.60M
183.60M – 183.60M
-19.2% YoY
|
211.14M
211.14M – 211.14M
+15.0% YoY
|
533.92M
533.92M – 533.92M
+152.9% YoY
|
619.35M
619.35M – 619.35M
+16.0% YoY
|
| Net Income |
58.75M
est: 178.20M (-67.0%)
|
89.62M
est: 143.32M (-37.5%)
|
255.54M
est: 316.10M (-19.2%)
|
405.33M
est: 381.38M (+6.3%)
|
636.89M
est: 348.33M (+82.8%)
|
922.58M
est: 1.10B (-16.1%)
|
1.09B
est: 174.71M (+525.2%)
|
1.16B
est: 208.66M (+454.4%)
|
141.20M
141.20M – 141.20M
-32.3% YoY
|
165.14M
165.14M – 165.14M
+16.9% YoY
|
311.43M
311.43M – 311.43M
+88.6% YoY
|
375.74M
375.74M – 375.74M
+20.7% YoY
|
| SGA |
3.13M
est: 19.90M (-84.3%)
|
34.41M
est: 18.61M (+84.9%)
|
72.19M
est: 54.12M (+33.4%)
|
77.13M
est: 62.77M (+22.9%)
|
128.71M
est: 403.91M (-68.1%)
|
150.34M
est: 262.34M (-42.7%)
|
246.13M
est: 19.61M (+1,155.1%)
|
117.43M
est: 23.14M (+407.5%)
|
18.70M
18.70M – 18.70M
-19.2% YoY
|
21.51M
21.51M – 21.51M
+15.0% YoY
|
54.39M
54.39M – 54.39M
+152.9% YoY
|
63.09M
63.09M – 63.09M
+16.0% YoY
|
| EPS |
10.66
est: 11.91 (-10.5%)
|
10.63
est: 9.63 (+10.4%)
|
24.91
est: 21.24 (+17.3%)
|
39.51
est: 25.62 (+54.2%)
|
51.10
est: 42.86 (+19.2%)
|
63.78
est: 73.11 (-12.8%)
|
73.02
est: 11.68 (+525.2%)
|
77.34
est: 13.95 (+454.4%)
|
9.44
9.44 – 9.44
-32.3% YoY
|
11.04
11.04 – 11.04
+16.9% YoY
|
20.82
20.82 – 20.82
+88.6% YoY
|
25.12
25.12 – 25.12
+20.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-02 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-06-01 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jaiprakash Rahulkumar Agarwal | MD & Executive Director | 9M | male |
| Lalit Kumar Agarwal | Whole-Time Director | 9M | male |
| Ramchandra Agarwal | Whole-Time Director | 9M | male |
| Vipin Agarwal | Chief Financial Officer | 4M | male |
| Yashee Agrawal | Company Secretary & Compliance Officer | 568.0K | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AGARIND.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
